About White Maple Pharmaceuticals Private Limited
Data last updated:
White Maple Pharmaceuticals Private Limited is a private limited company based in Dibrugarh, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24230AS2016PTC012342. Its GSTIN is 18AABCW8179N1ZF (Assam).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Premananda Das and Pabitra Kumar Baruah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Holding No.388 First Floor Prp Enclave Jalan Nagar Near Gm Hospital, Dibrugarh, Assam, India – 786005.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.9 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹11.72 Lakh (net margin 6.2%) and EBITDA of ₹15.17 Lakh (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 7% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹30 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website whitemaplepharma.com.
Company details
Contact details
White Maple Pharmaceuticals Private Limited's registered office is in Dibrugarh, Assam. Its website is whitemaplepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHolding No.388 First Floor Prp Enclave Jalan Nagar Near Gm Hospital, Dibrugarh, Assam, India – 786005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of White Maple Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of White Maple Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of White Maple Pharmaceuticals Private Limited, buy the company report.
Financials of White Maple Pharmaceuticals Private Limited
FY 2025 filings availableWhite Maple Pharmaceuticals Private Limited reported revenue of ₹1.9 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of White Maple Pharmaceuticals Private Limited, buy the company report.
Board of directors of White Maple Pharmaceuticals Private Limited
White Maple Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Premananda Das | Director | 12 Feb 2016 | 10 Years 9 Months | Current |
| Pabitra Kumar Baruah | Director | 12 Feb 2016 | 10 Years 9 Months | Current |
| Priteeshree Baruah | Director | 12 Feb 2016 | 10 Years 9 Months | Current |
Peer comparison
White Maple Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Best Laboratories Private Limited | ₹1.91 Cr (FY 2025) | -11.0% | New Delhi, Delhi, India | |||
| Durga Ji Life Sciences Private Limited | ₹1.91 Cr (FY 2024) | -4.0% | Lucknow, Uttar Pradesh, India | |||
| White Maple Pharmaceuticals Private Limitedthis company | ₹1.9 Cr (FY 2025) | ₹11.72 Lakh | 6.2% | -12.0% | 13 | Dibrugarh, Assam, India |
| Morksons Pharmaceuticals (India) Private Limited | ₹1.9 Cr (FY 2020) | -51.0% | New Delhi, Delhi, India | |||
| Biogenix Systems Private Limited | ₹1.9 Cr (FY 2025) | 77.0% | New Delhi, Delhi, India | |||
| Shimano Healthcare Private Limited | ₹1.9 Cr (FY 2024) | 8.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of White Maple Pharmaceuticals Private Limited, buy the company report.
Auditor
White Maple Pharmaceuticals Private Limited is audited by R K CHOUDHARY & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R K CHOUDHARY & CO | FY 2018 | 311058E |
Shareholding
The shareholding of White Maple Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of White Maple Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Feb 2020 | 100327969 | Syndicate Bank | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving White Maple Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for White Maple Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
White Maple Pharmaceuticals Private Limited has a workforce of 13 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 13 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of White Maple Pharmaceuticals Private Limited, buy the company report.
GST
White Maple Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AABCW8179N1ZF | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of White Maple Pharmaceuticals Private Limited, buy the company report.
Recent activity
White Maple Pharmaceuticals Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Pabitra Kumar Baruah was appointed as Director on 12 Feb 2016.
Frequently asked questions
White Maple Pharmaceuticals is an active private limited company based in Dibrugarh, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 February 2016 (10+ years old) and is registered under CIN U24230AS2016PTC012342.
White Maple Pharmaceuticals has 3 current directors:
- Premananda Das - Director
- Pabitra Kumar Baruah - Director
- Priteeshree Baruah - Director
The latest financial statements of White Maple Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of White Maple Pharmaceuticals is 18AABCW8179N1ZF, registered in Assam.
The CIN (Corporate Identification Number) of White Maple Pharmaceuticals is U24230AS2016PTC012342. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
White Maple Pharmaceuticals was incorporated on 12 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of White Maple Pharmaceuticals by revenue are Best Laboratories Private Limited, Durga Ji Life Sciences Private Limited, Morksons Pharmaceuticals (India) Private Limited, Biogenix Systems Private Limited, Shimano Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Pabitra Kumar Baruah was appointed as Director on 12 Feb 2016. Premananda Das was appointed as Director on 12 Feb 2016. Priteeshree Baruah was appointed as Director on 12 Feb 2016.
White Maple Pharmaceuticals can be reached through the website whitemaplepharma.com. Its registered office is in Dibrugarh, Assam, India.
The registered office of White Maple Pharmaceuticals is at Holding No.388 First Floor Prp Enclave Jalan Nagar Near Gm Hospital, Dibrugarh, Assam, India – 786005.
White Maple Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
